Multiple studies in breast, ovarian, and lung cancer provide convincing evidence for the role of PAR1 in regulating blood vessel formation and expression of angiogentic factors such as VEGF, IL-8, and GRO-α [2,5,7]. Here, F2R is linked to lung carcinoma.